Jump to content
  • Sign Up
×
×
  • Create New...
New feature: 1 Vote = 0.10€ for server Owner!

Novo Nordisk’s Wegovy, Apple Air, Palantir: Top Stories

Pelican Press

By Pelican Press,
in World News

 Share

Recommended Posts

  • Diamond Member
Pelican Press Warlord

Pelican Press 0

Posted
  • Diamond Member
Posted

This is the hidden content, please

Novo Nordisk’s Wegovy, Apple Air, Palantir: Top Stories

Wealth host Madison Mills explores several trending stocks this morning:

Novo Nordisk (NVO) is offering its GLP-1 weight-loss drug Wegovy at a substantial discount for uninsured patients.

Apple (AAPL) unveils its new MacBook Air featuring an m4 chip, iPad Air, and its Mac Studio desktop, the latter priced at $3,999.

Palantir Technologies (PLTR) receives an upgrade from William Blair analysts to Market Perform from Underperform.

To watch more expert insights and analysis on the latest market action, check out more Wealth here.

This post was written by Luke Carberry Mogan.



This is the hidden content, please

#Novo #Nordisks #Wegovy #Apple #Air #Palantir #Top #Stories

This is the hidden content, please

This is the hidden content, please

0

Join the conversation

You can post now and register later. If you have an account, sign in now to post with your account.

Guest
Unfortunately, your content contains terms that we do not allow. Please edit your content to remove the highlighted words below.
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

×
 Share
Go to topic listing

  • Vote for the server

    To vote for this server you must login.

    Jim Carrey Flirting GIF

  • Recently Browsing   0 members

    • No registered users viewing this page.

Important Information

Privacy Notice: We utilize cookies to optimize your browsing experience and analyze website traffic. By consenting, you acknowledge and agree to our Cookie Policy, ensuring your privacy preferences are respected.

  I accept